Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01974804 · ClinicalTrials.gov registry record
Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 30
- Enrollment target
NCT01974804: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01974804 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01974804 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Magnetic resonance imaging (MRI) is a diagnostic study that makes pictures of organs of the body using magnetic field and radio frequency pulses that can not be felt. The purpose of this study is to determine if new imaging methods can help tumor evaluation in the brain. The extra images will be obtained using diffusion and perfusion MRI techniques to assess early treatment response in patients with brain metastasis, and will be compared to methods currently being used.
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-10-25 |
| Est. Completion | 2022-12-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01974804
The ClinicalTrials.gov registry entry for NCT01974804 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT01974804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01974804 about?
NCT01974804 is a clinical study titled "Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis". Magnetic resonance imaging (MRI) is a diagnostic study that makes pictures of organs of the body using magnetic field and radio frequency pulses that can not be felt. The purpose of this study is to determine if new imaging methods can help tumor evaluation in the brain. The extra images will be obt...
What is the current status of trial NCT01974804?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-10-25. Estimated completion is 2022-12-28.
What interventions are being tested in trial NCT01974804?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT01974804?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.